Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.

BACKGROUND:Rituximab is a promising steroid sparing agent used in the treatment of moderate to severe pemphigus vulgaris. Its exact place in the algorithm of pemphigus treatment, vis-à-vis other, conventional adjuvant therapy (CAT) is not known. OBJECTIVE:To describe and compare disease course outco...

Full description

Bibliographic Details
Main Authors: Ashwin Agarwal, Russell P Hall, Lionel L Bañez, Adela R Cardones
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6155499?pdf=render